In patients with acquired resistance, studies have found that interferon-γ (IFN-γ) secreted by both TILs and tumor antigen-specific T cells can mediate the upregulation of PD-L1 expression after tumor antigen recognition. This evidence concerns the gene IFNG and neoplasm.